The present invention relates to a novel compound having a function of inhibiting RORγ activity. The present invention also relates to pharmaceutical composition comprising the compound, a use of the compound in treating or preventing autoimmune diseases, inflammatory diseases, metabolic diseases, or cancer diseases.
-
Page/Page column 81; 82
(2015/09/28)
2-(2,6-dichlorophenyl)-diarylimidazoles
The invention is directed to compounds of formula (I), which are valuable therapeutics for the treatment of cancer and related diseases.
-
Page/Page column 8
(2010/11/29)
More Articles about upstream products of 616196-04-4